A Drug-drug Interaction Study to Investigate the Effect of Coadministration of EDP-305 on the PK of a Combined Oral Contraceptive in Healthy Female Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 27, 2018

Primary Completion Date

June 4, 2019

Study Completion Date

June 18, 2019

Conditions

NASH - Nonalcoholic Steatohepatitis

Interventions

DRUG

EDP-305

Subjects will receive EDP-305 on on Days 11 through 21 of cycle 3

DRUG

Oral Contraceptive

Subjects will receive active Oral Contraceptive on Days 1-21 and inert OC on Days 22-28 of cycles 1, 2 and 3

Trial Locations (1)

Covance Clinical Research Unit, Madison